Vimarsana
Biggest News Aggregation in the World

Page 4 - Panic Disorder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Panic Disorder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Panic Disorder Today - Breaking & Trending Today

Avoidance Predicts Worse Long-term Outcomes in OCD - Vimarsana News

Avoidance Predicts Worse Long-term Outcomes in OCD

Behavioral avoidance could limit the long-term of a widely used treatment for obsessive compulsive disorder, a new analysis shows.

What's been considered America's 'gold standard' of autism therapy may not work — and those who have been through it are pushing back - Vimarsana News

What's been considered America's 'gold standard' of autism therapy may not work — and those who have been through it are pushing back

The 74 does a deep dive into applied behavior analysis for autism therapy, its history, progression, and studies' results throughout the years.

What's been considered America's 'gold standard' of autism therapy may not work — and those who have been through it are pushing back - Vimarsana News

What's been considered America's 'gold standard' of autism therapy may not work — and those who have been through it are pushing back

The 74 does a deep dive into applied behavior analysis for autism therapy, its history, progression, and studies' results throughout the years.

The Fine Art (and Science) of Nonprescribing - Vimarsana News

The Fine Art (and Science) of Nonprescribing

For many psychiatric conditions, psychotherapy, not medication, is the preferred first-line treatment.

Strides Pharma Science Singapore arm gets USFDA nod for Major Depressive Disorder drug Fluoxetine - Vimarsana News

Strides Pharma Science Singapore arm gets USFDA nod for Major Depressive Disorder drug Fluoxetine

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug Prozac Tablets of Eli Lilly.